|By PR Newswire||
|August 25, 2014 04:01 PM EDT||
NEWARK, Calif., Aug. 25, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) today announced that it will be presenting at the Morgan Stanley 2014 Global Healthcare Conference in New York City.
The presentation at the Morgan Stanley conference is scheduled for 2:40 pm ET (11:40 am PT) on Wednesday September 10, 2014. The presentation will be webcast, and the webcast can be accessed via the Investor Relations page of the Depomed website at www.depomed.com. A recording of the webcast will be archived for 30 days on the company's website.
Depomed is a specialty pharmaceutical company that commercializes products for pain and CNS disorders. Gralise® (gabapentin) is a once-daily treatment approved for the management of postherpetic neuralgia. CAMBIA® (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug indicated for acute treatment of migraine attacks with or without aura in adults (18 years of age or older). Zipsor® (diclofenac potassium) Liquid Filled Capsules is a non-steroidal anti-inflammatory drug indicated for relief of mild to moderate acute pain in adults. Lazanda® (fentanyl) Nasal Spray is an intranasal fentanyl drug used to manage breakthrough pain in adults (18 years of age or older) who are already routinely taking other opioid pain medicines around-the-clock for cancer pain. Gralise and various partner product candidates are formulated with Depomed's proven, proprietary Acuform® drug delivery technology. Additional information about Depomed may be found at www.depomed.com.
August J. Moretti
Depomed, Inc. 510.744.8000
SOURCE Depomed, Inc.
SYS-CON Events announced today that SoftNet Solutions will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. SoftNet Solutions specializes in Enterprise Solutions for Hadoop and Big Data. It offers customers the most open, robust, and value-conscious portfolio of solutions, services, and tools for the shortest route to success with Big Data. The unique differentiator is the ability to architect and ...
Oct. 26, 2016 03:30 PM EDT Reads: 1,073
Oct. 26, 2016 02:45 PM EDT Reads: 327
Oct. 26, 2016 02:15 PM EDT Reads: 1,284
Oct. 26, 2016 02:00 PM EDT Reads: 994
Oct. 26, 2016 01:30 PM EDT Reads: 1,108
Oct. 26, 2016 01:15 PM EDT Reads: 1,394
Oct. 26, 2016 01:00 PM EDT Reads: 5,012
Oct. 26, 2016 12:45 PM EDT Reads: 8,562
Oct. 26, 2016 12:45 PM EDT Reads: 1,166
Oct. 26, 2016 12:45 PM EDT Reads: 609
Oct. 26, 2016 12:45 PM EDT Reads: 419
Oct. 26, 2016 12:30 PM EDT Reads: 953
Oct. 26, 2016 12:30 PM EDT Reads: 3,956
Oct. 26, 2016 12:15 PM EDT Reads: 2,229
Oct. 26, 2016 12:15 PM EDT Reads: 1,606